Home Page
20:22:59 EDT Wed 01 Oct 2014
Enter Symbol
or Name
USA
CA



COVIDIEN PLC NEW
Symbol U : COV
Recent Sedar Documents

Covidien to Present at Leerink Swann Conference

2013-02-11 07:00 ET - News Release


Company Website: http://www.covidien.com
MANSFIELD, Mass. -- (Business Wire)

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Leerink Swann 2013 Global Healthcare Conference in New York, New York, on February 14, 2013. James C. Clemmer, President, Medical Supplies, will discuss the Company in a presentation scheduled to begin at 8:00AM ET.

A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts:

Covidien
Bruce Farmer, 508-452-4372
Vice President
Public Relations
bruce.farmer@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com

Source: Covidien

© 2014 Canjex Publishing Ltd. All rights reserved.